89Bio up after directors Grunberg and Kariv purchased shares, Addus Homecare down after director First sold shares Welcome to "Fly Insider," The Fly's weekly recap of notable insider stock transactions.
NOTABLE INSIDER PURCHASES: Significant insider purchases reported in the prior week from November 11 through November 15 include:
- CEO of Agios Pharmaceuticals (AGIO) Jacqualyn Fouse purchased 40,322 shares of company stock at an average price of $31.00 per share for a total transaction value of $1,249,982
- Director of 89Bio (ETNB) Gregory Grunberg purchased 575,000 shares of company stock at an average price of $16.00 per share for a total transaction value of $9,200,000; Director Tomer Kariv purchased 250,000 shares of company stock at an average price of $16.00 per share for a total transaction value of $4,000,000
- Chairman of Galera Therapeutics (GRTX) Michael Powell purchased 750,000 shares of company stock at an average price of $12.00 per share for a total transaction value of $9,000,000
- Director of Arvinas (ARVN) Liam Ratcliffe purchased 680,000 shares of company stock at an average price of $22 per share for a total transaction value of $14,960,000
- Director of Trinity Industries (TRN) Brandon Boze purchased 677,500 shares of company stock at an average price of $21.47 per share for a total transaction value of $14,547,754.
NOTABLE INSIDER SALES: Significant insider sales reported in the prior week from November 11 through November 15 include:
- Director of Addus Homecare (ADUS) Mark First sold 690,000 shares of company stock at an average price of $82.55 per share for a total transaction value of $56,959,500
- Chairman of Air Lease (AL) Steven Udar-hazy sold 87,888 shares of company stock at an average price of $45.36 per share for a total transaction value of $3,986,336
- Chairman of Amedisys (AMED) Donald Washburn sold 8,667 shares of company stock at an average price of $149.96 per share for a total transaction value of $1,299,721
- CFO of Blackbaud (BLKB) Anthony Boor sold 2,050 shares of company stock at an average price of $80.76 per share for a total transaction value of $165,558; Chairman Andrew Leitch sold 3,449 shares of company stock at an average price of $81.33 per share for a total transaction value of $280,507
- Director of BOK Financial (BOKF) Steven Bangert sold 8,000 shares of company stock at an average price of $81.92 per share for a total transaction value of $655,360.
NOTABLE PRICE MOVEMENT AFTER INSIDER TRANSACTIONS: Shares of 89Bio are up approximately 30% since directors Gregory Grunberg and Tomer Kariv purchased shares of company stock while shares of Addus Homecare are down approximately 2% since director Mark First sold 690,000 shares of company stock.
Symbols:
AGIO ETNB GRTX ARVN TRN ADUS AL AMED BLKB BOKF Keywords: insider trading, insider buying, insider selling, executive trading, executive buying, executive selling, stock transactions, SEC